The DigitalHealthX Weekly | Oct 26, 2026 Edition

CareValidate has launched an expanded hormone replacement therapy (HRT) pathway to help telehealth brands, employers, and healthcare businesses deliver menopause and perimenopause care. The offering combines clinical and regulatory infrastructure with licensed providers, pharmacy fulfillment, and multiple hormone therapy options, including progesterone, DHEA, and estradiol in different delivery formats. The expansion aims to simplify the launch and management of HRT programs while strengthening access to personalized women's healthcare through clinical oversight and ongoing support.